Classifications

I) clinical cure:

drugs used to treat the acute attack of malaria by acting on the erythrocyte stage of the parasite

  1. chloroquine-sensitive malaria: Chloroquine
  2. chloroquine-resistance malaria:

II) chemoprophylaxis:

  1. clinical prophylaxis: Chloroquine, proguanil, & fansidar = sulphadoxine + pyremethamine suppress the clinical manifestation of malaria by killing parasite as soon as they reach the RBCs .

  2. antirelapse therapy: Primaquine in P.vivax and ovale only by killing the dormant stage in liver;

  3. prevent transmission: Primaquine + folate antagonists; progunail ,pyremethamine by killing the gametocytes:

PATHOPHYSIOLOGY and life cycle:

  • Anopheles mosquito inoculates sporozoites to human .
  • Sporozoites invade liver cells ( primary tissue phase).
  • Merozoites released from liver & invade erythrocytes .
  • Merozoites multiply, red cell enlarges ( blood schizont).
  • blood schizont ruptures, merozoites invade more RBCs.
  • Repeated cycles cause clinical illness, fever, etc.
  • In P. vivax & P. ovale some merozoite invade liver cellsZ ( secondary tissue phase) & become dormant ( hypnozoites ) hypnozoites may develop again and cause relapse.
  • In P. falciparum & P. malariae no second liver phase.
  • Some merozoite — gametocytes— mosquito — sporozoites
Common symptoms

Recurrent fever and chills, splenomegaly

Life cycle of malaria